Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-13
5:13 pm
Unchanged
13GCelularity Inc.
CELU
STARR INTERNATIONAL CO INC15,281,389
10.54%
0
(Unchanged)
View
2023-02-13
5:12 pm
Purchase
13GCelularity Inc.
CELU
C V STARR & CO INC7,640,693
5.27%
7,640,693increase
(New Position)
View
2023-02-06
06:01 am
Unchanged
13GCelularity Inc.
CELU
UNITED THERAPEUTICS Corp
UTHR
7,968,848
5.5%
0
(Unchanged)
View
2023-02-03
07:28 am
Purchase
13GCelularity Inc.
CELU
UNITED THERAPEUTICS Corp
UTHR
7,968,848
6.51%
7,968,848increase
(New Position)
View
2022-02-04
12:07 pm
Unchanged
13GCelularity Inc.
CELU
Weiss Asset Management LP0
0%
0
(Unchanged)
View
2022-01-27
08:13 am
Unchanged
13GCelularity Inc.
CELU
HIGHBRIDGE CAPITAL MANAGEMENT LLC0
0%
0
(Unchanged)
View
2021-07-26
5:19 pm
Purchase
13GCelularity Inc.
CELU
Human Longevity Inc.7,012,574
5.7%
7,012,574increase
(New Position)
View
2021-07-26
5:16 pm
Purchase
13DCelularity Inc.
CELU
Hariri Robert J10,296,668
8.2%
10,296,668increase
(New Position)
View
2021-07-26
5:10 pm
Purchase
13GCelularity Inc.
CELU
BRISTOL MYERS SQUIBB CO
BMY
11,953,274
9.9%
11,953,274increase
(New Position)
View
2021-07-26
4:12 pm
Purchase
13DCelularity Inc.
CELU
Dragasac Ltd36,592,596
28.4%
36,592,596increase
(New Position)
View
2021-07-26
12:19 pm
Purchase
13GCelularity Inc.
CELU
STARR INTERNATIONAL CO INC15,281,389
11.8%
15,281,389increase
(New Position)
View
2021-07-23
06:02 am
Purchase
13GCelularity Inc.
CELU
Sorrento Therapeutics Inc.
SRNEQ
20,422,124
16.7%
20,422,124increase
(New Position)
View
2021-07-15
1:21 pm
Sale
13GGX Acquisition Corp.
GXGX
Feis Lawrence0
0%
-1,455,253decrease
(Position Closed)
View
2021-07-08
3:49 pm
Purchase
13GGX Acquisition Corp.
GXGX
Feis Lawrence1,455,253
11.57%
815,236increase
(+127.38%)
View
2021-06-01
5:13 pm
Purchase
13GGX Acquisition Corp.
GXGX
HIGHBRIDGE CAPITAL MANAGEMENT LLC1,584,052
5.51%
1,584,052increase
(New Position)
View
2021-05-27
12:40 pm
Purchase
13GGX Acquisition Corp.
GXGX
Feis Lawrence640,017
5.09%
640,017increase
(New Position)
View
2021-03-31
2:21 pm
Purchase
13GGX Acquisition Corp.
GXGX
Weiss Asset Management LP2,446,179
8.51%
2,446,179increase
(New Position)
View
2021-02-16
06:04 am
Sale
13GGX Acquisition Corp.
GXGX
RP Investment Advisors LP0
0%
-1,653,259decrease
(Position Closed)
View
2021-02-09
08:47 am
Sale
13GGX Acquisition Corp.
GXGX
Polar Asset Management Partners Inc.267,128
0.93%
-1,932,872decrease
(-87.86%)
View
2021-02-01
06:31 am
Sale
13GGX Acquisition Corp.
GXGX
Linden Capital L.P.517,767
1.8%
-2,058,233decrease
(-79.90%)
View
Goto 0, 1, Next